Skip to main content
. Author manuscript; available in PMC: 2012 Nov 2.
Published in final edited form as: J Am Coll Surg. 2011 Apr;212(4):638–650. doi: 10.1016/j.jamcollsurg.2011.01.004

Table 3.

Univariate and Multivariate Regression Analysis of Predictors for Major Complications

Variable Univariate analysis
Multivariate analysis
Crude odds ratio (95% CI) p Value Adjusted odds ratio (95% CI) p Value
Age 1.03 (0.99–1.05) 0.066 1.03 (0.99–1.06) 0.08

Male gender 1.23 (0.59–2.59) 0.58

Diabetes 0.64 (0.28–1.49) 0.30

ASA score

 2 Reference Reference

 3 1.32 (0.58–3.02) 0.51 1.27 (0.53–3.01) 0.70

 4 5.81 (1.59–21.23) 0.008* 4.31 (1.06–17.49) 0.041*

Platelet count <150/nL 2.43 (1.15–5.13) 0.020* 2.77 (1.13–6.76) 0.026*

Child score 1.41 (1.02–1.96) 0.040* 1.09 (0.73–1.64) 0.68

MELD score 1.09 (1.00–1.18) 0.046* 1.08 (0.98–1.20) 0.21

Ruptured lesion 0.69 (0.15–3.15) 0.63

Tumor >Milan criteria 2.56 (1.02–6.44) 0.045* 3.95 (1.43–10.94) 0.008*

Major resection 0.64 (0.32–1.27) 0.20
*

Statistically significant p values.

ASA, American Society of Anesthesiologists; MELD, model for end-stage liver disease.